The Risk Factors and Optimal Prevention Strategies of VTE in Sickle Cell Disease – RPTH Journal
RPTH Journal shared on LinkedIn about a recent article by Neha Bhasin et al, adding:
”Risk factors for venous thromboembolism in sickle cell disease
Sickle cell disease (SCD) is well known to increase the risk of venous thromboembolism (VTE),but who is most at risk, and how often does VTE recur?
A new retrospective study in RPTH examined 719 individuals with SCD over a 10-year period to answer these questions.
Key findings from 64 patients who developed VTE:
- 8.9% of the cohort developed at least one VTE
- VTE recurrence rate: 31%
Major risk factors:
- History of VTE
- History of stroke
- ≥6 hospitalisations in 12 months
Additional risk factors: hormonal therapy, smoking , and central venous catheter use
Prospective studies are needed to validate these risk factors and evaluate optimal prevention strategies.”
Title: Risk factors for venous thromboembolism in sickle cell disease
Authors: Neha Bhasin, Li Zhang, Ayotola Ajayi, Seva Patel, Taylor Imai, Shreya Agarwal
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 19, 2026, 08:20Cory Dugan: The IRONWOMAN Trial Individual Responses to IV Iron Therapy in Active Women
-
Oct 19, 2026, 07:36Johannes Kaesmacher: Cerebral No-Reflow After Thrombectomy Toward a Standardized Definition
-
Oct 19, 2026, 07:33Beth Psaila: Highlights from IACH Annual Meeting and MPN Horizons
-
Oct 19, 2026, 07:29Wolfgang Miesbach: Can Losartan Activate Brown Fat? – Nature Study Explores New Therapeutic Link
-
Oct 19, 2026, 07:22Ruben Mesa: Honored to Speak at the Tandem MPN Meetings of IACH
-
Oct 19, 2026, 07:19Saneha Anjum Shaikh: Parul University Partners with Raktasevak Bike Ride 2026 for Blood Donation Drive
-
Oct 19, 2026, 07:09Alejandro González Veliz: No ST Elevation Does Not Guarantee an Open Coronary Artery
-
Oct 19, 2026, 06:02Thomas Dayspring: Vascular Resilience – What Is It and How Can We Measure It?
-
Oct 19, 2026, 05:53Kevon Dindial: Collaboration for Better Childhood Cancer Outcomes